4d Molecular Therapeutics In shares owned by Citadel Advisors
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in 4d Molecular Therapeutics In by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $2.2M | 200k | 10.81 |
| 2024-06-30 | $1.9M | 89k | 20.99 |
| 2024-03-31 | $5.3M | 166k | 31.86 |
| 2023-12-31 | $1.0M | 50k | 20.26 |
| 2023-09-30 | $2.0M | 153k | 12.73 |
| 2023-06-30 | $741k | 41k | 18.07 |
| 2023-03-31 | $398k | 23k | 17.19 |
| 2022-12-31 | $637k | 29k | 22.21 |
| 2022-06-30 | $2.4M | 338k | 6.98 |
| 2022-03-31 | $1.9M | 126k | 15.10 |
| 2021-12-31 | $915k | 42k | 21.96 |
| 2021-09-30 | $374k | 14k | 27.00 |
| 2021-06-30 | $658k | 27k | 24.09 |
| 2021-03-31 | $981k | 20k | 50.00 |
| 2020-12-31 | $2.2M | 53k | 41.46 |